The clinical characterization of the adult patient with depression aimed at personalization of management

M Maj, DJ Stein, G Parker, M Zimmerman… - World …, 2020 - Wiley Online Library
Depression is widely acknowledged to be a heterogeneous entity, and the need to further
characterize the individual patient who has received this diagnosis in order to personalize …

The severity of psychiatric disorders

M Zimmerman, TA Morgan, K Stanton - World Psychiatry, 2018 - Wiley Online Library
The issue of the severity of psychiatric disorders has great clinical importance. For example,
severity influences decisions about level of care, and affects decisions to seek government …

[HTML][HTML] Baseline depression severity as moderator on depression outcomes in psychotherapy and pharmacotherapy

A Tröger, C Miguel, M Ciharova, N de Ponti… - Journal of affective …, 2024 - Elsevier
Background Evidence-based treatments for adult depression include psychotherapy and
pharmacotherapy, yet little is known about how baseline depression severity moderates …

Desvenlafaxine in the treatment of major depression: an updated overview

TR Norman, JS Olver - Expert opinion on pharmacotherapy, 2021 - Taylor & Francis
Introduction: Major depressive disorder (MDD) remains one of the most prevalent mental
health conditions. It is a chronic, relapsing condition and despite multiple treatment options …

Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper

G Sampogna, F Caraci, C Carmassi… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Major depressive disorder (MDD) is a common severe mental disorder,
requiring a tailored and integrated treatment. Several approaches are available including …

Association study between serotonin transporter gene and fluoxetine response in Mexican patients with major depressive disorder

B Camarena, D Álvarez-Icaza… - Clinical …, 2019 - journals.lww.com
Objective Pharmacogenetic studies have identified genetic variants associated with
fluoxetine response in patients with major depression disorder (MDD). The serotonin …

Severity and the treatment of depression: a review of two controversies

M Zimmerman - The Journal of Nervous and Mental Disease, 2019 - journals.lww.com
Severity is an important consideration in treatment decision-making for depression. Two
controversies in the treatment of depression are related to the issue of severity. First, are …

Enfermedades y problemas de salud mental: un análisis crítico a los reportes de la relación entre covid-19 y depresión.

A Cavieres, P López - Revista chilena de neuro-psiquiatría, 2024 - SciELO Chile
Método: Revisión crítica no sistemática de la literatura Resultados: Siguiendo a Horwitz y
Wakefield, planteamos que estas investigaciones presentan problemas metodológicos …

Population pharmacokinetics of desvenlafaxine: Pharmacokinetics in Korean versus US populations

AI Nichols, S Liao, R Abbas - Clinical Pharmacology in Drug …, 2018 - Wiley Online Library
Desvenlafaxine exposure in Korean and US populations was compared using population
pharmacokinetic (PK) analysis. Data from a single‐and multiple‐dose study of …

[HTML][HTML] Antidepressant Treatment of Depression in the Elderly: Efficacy and Safety Considerations

TR Norman - OBM Neurobiology, 2021 - lidsen.com
Depression in the elderly is a significant clinical problem which is likely to endure as an
ongoing issue as the cohort of individuals aged over 65years continues to increase as a …